1 | ranges | 1,890 |
2 | percentile | 1,875 |
3 | humidity | 1,342 |
4 | z-score | 595 |
5 | percentiles | 394 |
6 | z-scores | 345 |
7 | centile | 215 |
8 | anniversary | 47 |
9 | centiles | 30 |
10 | humidities | 23 |
11 | acquisita | 12 |
12 | ≤-2.5 | 12 |
13 | ca-mssa | 10 |
14 | camber | 10 |
15 | cfu/carcass | 9 |
16 | ≤3.2 | 8 |
17 | 11y | 7 |
18 | mcfb | 6 |
19 | down-pack | 5 |
20 | nlmixed | 5 |
21 | picturata | 5 |
22 | small-worldness | 5 |
23 | bioavailabilty | 4 |
24 | coefficent | 4 |
25 | gvr | 4 |
26 | °cd | 4 |
27 | cals | 3 |
28 | dinitrotoluene | 3 |
29 | fold-changes | 3 |
30 | hfb2 | 3 |
31 | normogram | 3 |
32 | pmca50 | 3 |
33 | risk=0.86 | 3 |
34 | risk=1.20 | 3 |
35 | risk=1.7 | 3 |
36 | +10°c | 2 |
37 | 1.79+/-0.39 | 2 |
38 | 19.0-24.9 | 2 |
39 | 3.680 | 2 |
40 | 3/min | 2 |
41 | 5.1mm | 2 |
42 | 58- | 2 |
43 | 61/59 | 2 |
44 | 6686 | 2 |
45 | =0.877 | 2 |
46 | area-under-the-hba | 2 |
47 | bvba | 2 |
48 | cal/pd | 2 |
49 | dystrophica | 2 |
50 | hypaque | 2 |
51 | map/ne | 2 |
52 | mr-spectroscopy | 2 |
53 | rate=1.2 | 2 |
54 | risk=0.36 | 2 |
55 | risk=0.72 | 2 |
56 | risk=0.75 | 2 |
57 | risk=1.1 | 2 |
58 | risk=1.13 | 2 |
59 | risk=1.17 | 2 |
60 | vs.10th | 2 |
61 | ytss | 2 |
62 | ≥0.50 | 2 |
63 | ≥15/h | 2 |
64 | ≥37·5°c | 2 |
65 | 'evaporative | 1 |
66 | +0.017 | 1 |
67 | -2.6+/-0.5 | 1 |
68 | -2.7+/-0.5 | 1 |
69 | -86+/-75 | 1 |
70 | -methyl-2-oxobutyl | 1 |
71 | .78-.92 | 1 |
72 | 0.88-log1.01 | 1 |
73 | 1.26-2.42 | 1 |
74 | 1.490ng/ml | 1 |
75 | 1.52+/-0.07 | 1 |
76 | 100°f+ | 1 |
77 | 1200-1400°c | 1 |
78 | 14,400/μl | 1 |
79 | 14±3.1°c | 1 |
80 | 15,000-19,999 | 1 |
81 | 169±12cm | 1 |
82 | 18.5-22.9kg/m | 1 |
83 | 19.3-26.4 | 1 |
84 | 19.8-25 | 1 |
85 | 2.0+/-0.39mg/dl | 1 |
86 | 20,000-24,999 | 1 |
87 | 21.7±3.7 | 1 |
88 | 210g | 1 |
89 | 22.1±1.7kg/m | 1 |
90 | 22.3±1.6kg/m | 1 |
91 | 22±2kg/m | 1 |
92 | 23.0-27.4kg/m | 1 |
93 | 24.0±2.2 | 1 |
94 | 24.1±11 | 1 |
95 | 24.4+/-4.0 | 1 |
96 | 24.9±0.6kg/m | 1 |
97 | 25,000-29,999 | 1 |
98 | 25.2±1.0 | 1 |
99 | 25.96+/-3.7 | 1 |
100 | 26±1kg/m | 1 |
101 | 26·4 | 1 |
102 | 28.0+/-7.4 | 1 |
103 | 28±3.5 | 1 |
104 | 29+/-4.3 | 1 |
105 | 29±5 | 1 |
106 | 31.0±3.2years | 1 |
107 | 31.6+/-5.3 | 1 |
108 | 31.8±2.2 | 1 |
109 | 32.2±1.0kg/m | 1 |
110 | 33.8±3.9 | 1 |
111 | 33.9+/-1.1 | 1 |
112 | 33±5kg/m | 1 |
113 | 34.2yr | 1 |
114 | 35.0/100,000 | 1 |
115 | 35months | 1 |
116 | 36.5/h | 1 |
117 | 36.5±20.5 | 1 |
118 | 36.9±5.7 | 1 |
119 | 36·11 | 1 |
120 | 40.0+ | 1 |
121 | 40y | 1 |
122 | 41ng/l | 1 |
123 | 47-96°c | 1 |
124 | 47.8+/-4.9 | 1 |
125 | 48.2±10.7 | 1 |
126 | 489-1696g | 1 |
127 | 5000-14,999 | 1 |
128 | 58.6±1.0 | 1 |
129 | 58.7+/-16.2 | 1 |
130 | 6-86years | 1 |
131 | 61.0±13.4 | 1 |
132 | 62·8°c | 1 |
133 | 64±12years | 1 |
134 | 68±12years | 1 |
135 | 72.29+/-6.92 | 1 |
136 | 85-97th | 1 |
137 | =14.48±1.60 | 1 |
138 | =29.7 | 1 |
139 | arabesk | 1 |
140 | benefit-or | 1 |
141 | benefit=1.07 | 1 |
142 | blueshifts | 1 |
143 | bmi-p | 1 |
144 | cfu/serving | 1 |
145 | cost-effectiveness.we | 1 |
146 | cost/child | 1 |
147 | cost/responder | 1 |
148 | cost/treated | 1 |
149 | dimethylethanamine | 1 |
150 | dimethylthiazol-2-yl | 1 |
151 | eckenrode | 1 |
152 | elipscity | 1 |
153 | hazard=0.52 | 1 |
154 | hazard=2.61 | 1 |
155 | hazard=2.72 | 1 |
156 | humidity-transorally | 1 |
157 | hydroxy-1 | 1 |
158 | hydroxyhexanoate | 1 |
159 | hypopnoe | 1 |
160 | inflammatory-analgesic | 1 |
161 | m=28.0 | 1 |
162 | mean=32.7±3.7 | 1 |
163 | memory-i | 1 |
164 | mentaux | 1 |
165 | methyl-1,2,3,4-tetrahydroisoquinoline | 1 |
166 | odds=3.5 | 1 |
167 | ohe1/4-ohe1 | 1 |
168 | pm400 | 1 |
169 | pre-lagb | 1 |
170 | pre-rygbp | 1 |
171 | qmc | 1 |
172 | rank.=6.8 | 1 |
173 | rank=3.93 | 1 |
174 | rank=9.953 | 1 |
175 | rate=0.6 | 1 |
176 | rate=1.56-1.99 | 1 |
177 | response=0.0036 | 1 |
178 | risk:1.67 | 1 |
179 | risk=0.05 | 1 |
180 | risk=0.11 | 1 |
181 | risk=0.38 | 1 |
182 | risk=0.39 | 1 |
183 | risk=0.46 | 1 |
184 | risk=0.51 | 1 |
185 | risk=0.52 | 1 |
186 | risk=0.54 | 1 |
187 | risk=0.59 | 1 |
188 | risk=0.60 | 1 |
189 | risk=0.61 | 1 |
190 | risk=0.62 | 1 |
191 | risk=0.70 | 1 |
192 | risk=0.73 | 1 |
193 | risk=0.76 | 1 |
194 | risk=0.84 | 1 |
195 | risk=0.85 | 1 |
196 | risk=0.91 | 1 |
197 | risk=0.96 | 1 |
198 | risk=0.98 | 1 |
199 | risk=1.06 | 1 |
200 | risk=1.063 | 1 |
201 | risk=1.14 | 1 |
202 | risk=1.2 | 1 |
203 | risk=1.21 | 1 |
204 | risk=1.27 | 1 |
205 | risk=1.33 | 1 |
206 | risk=1.36 | 1 |
207 | risk=1.78 | 1 |
208 | risk=1.79 | 1 |
209 | risk=2.22 | 1 |
210 | risk=2.57 | 1 |
211 | risk=3.04 | 1 |
212 | risk=3.51 | 1 |
213 | risk=3.83 | 1 |
214 | risk=4.4 | 1 |
215 | risk=4.47 | 1 |
216 | risk=4.7 | 1 |
217 | risk=8.8 | 1 |
218 | risks=0.79 | 1 |
219 | rr=-0.169-0.0499*hdl-c | 1 |
220 | rr=-0.367+0.077*hdl-c | 1 |
221 | rr=1.07-0.185*hdl-c | 1 |
222 | s-fimh1-25 | 1 |
223 | score≥5=17 | 1 |
224 | seriality | 1 |
225 | serotec | 1 |
226 | spc30 | 1 |
227 | superreviewer | 1 |
228 | terms.however | 1 |
229 | tert-butyl-phenylaminooxalyl | 1 |
230 | tetrahydro-4h-carbazol-4-one | 1 |
231 | weibul | 1 |
232 | z-score=-0.63 | 1 |
233 | z-score=0.6 | 1 |
234 | z-score≤-1.5 | 1 |
235 | ~30kg/m | 1 |
236 | ~42.5°c | 1 |
237 | µv/y | 1 |
238 | μv/y | 1 |
239 | ∼0.7°c | 1 |
240 | ∼1◦c | 1 |
241 | ∼39.0°c | 1 |
242 | ≈34°c | 1 |
243 | ≈39°c | 1 |
244 | ≤-2.0 | 1 |
245 | ≤-2.8 | 1 |
246 | ≤-3.0 | 1 |
247 | ≤24kg/m | 1 |
248 | ≤43.0 | 1 |
249 | ≥25kg/m | 1 |
250 | ≥38·0°c | 1 |
251 | ≥40.0 | 1 |
252 | ≥500copies/ml | 1 |
253 | ≥5µg/dl | 1 |
1 | 'evaporative | 1 |
2 | +0.017 | 1 |
3 | +10°c | 2 |
4 | -2.6+/-0.5 | 1 |
5 | -2.7+/-0.5 | 1 |
6 | -86+/-75 | 1 |
7 | -methyl-2-oxobutyl | 1 |
8 | .78-.92 | 1 |
9 | 0.88-log1.01 | 1 |
10 | 1.26-2.42 | 1 |
11 | 1.490ng/ml | 1 |
12 | 1.52+/-0.07 | 1 |
13 | 1.79+/-0.39 | 2 |
14 | 100°f+ | 1 |
15 | 11y | 7 |
16 | 1200-1400°c | 1 |
17 | 14,400/μl | 1 |
18 | 14±3.1°c | 1 |
19 | 15,000-19,999 | 1 |
20 | 169±12cm | 1 |
21 | 18.5-22.9kg/m | 1 |
22 | 19.0-24.9 | 2 |
23 | 19.3-26.4 | 1 |
24 | 19.8-25 | 1 |
25 | 2.0+/-0.39mg/dl | 1 |
26 | 20,000-24,999 | 1 |
27 | 21.7±3.7 | 1 |
28 | 210g | 1 |
29 | 22.1±1.7kg/m | 1 |
30 | 22.3±1.6kg/m | 1 |
31 | 22±2kg/m | 1 |
32 | 23.0-27.4kg/m | 1 |
33 | 24.0±2.2 | 1 |
34 | 24.1±11 | 1 |
35 | 24.4+/-4.0 | 1 |
36 | 24.9±0.6kg/m | 1 |
37 | 25,000-29,999 | 1 |
38 | 25.2±1.0 | 1 |
39 | 25.96+/-3.7 | 1 |
40 | 26±1kg/m | 1 |
41 | 26·4 | 1 |
42 | 28.0+/-7.4 | 1 |
43 | 28±3.5 | 1 |
44 | 29+/-4.3 | 1 |
45 | 29±5 | 1 |
46 | 3.680 | 2 |
47 | 3/min | 2 |
48 | 31.0±3.2years | 1 |
49 | 31.6+/-5.3 | 1 |
50 | 31.8±2.2 | 1 |
51 | 32.2±1.0kg/m | 1 |
52 | 33.8±3.9 | 1 |
53 | 33.9+/-1.1 | 1 |
54 | 33±5kg/m | 1 |
55 | 34.2yr | 1 |
56 | 35.0/100,000 | 1 |
57 | 35months | 1 |
58 | 36.5/h | 1 |
59 | 36.5±20.5 | 1 |
60 | 36.9±5.7 | 1 |
61 | 36·11 | 1 |
62 | 40.0+ | 1 |
63 | 40y | 1 |
64 | 41ng/l | 1 |
65 | 47-96°c | 1 |
66 | 47.8+/-4.9 | 1 |
67 | 48.2±10.7 | 1 |
68 | 489-1696g | 1 |
69 | 5.1mm | 2 |
70 | 5000-14,999 | 1 |
71 | 58- | 2 |
72 | 58.6±1.0 | 1 |
73 | 58.7+/-16.2 | 1 |
74 | 6-86years | 1 |
75 | 61.0±13.4 | 1 |
76 | 61/59 | 2 |
77 | 62·8°c | 1 |
78 | 64±12years | 1 |
79 | 6686 | 2 |
80 | 68±12years | 1 |
81 | 72.29+/-6.92 | 1 |
82 | 85-97th | 1 |
83 | =0.877 | 2 |
84 | =14.48±1.60 | 1 |
85 | =29.7 | 1 |
86 | acquisita | 12 |
87 | anniversary | 47 |
88 | arabesk | 1 |
89 | area-under-the-hba | 2 |
90 | benefit-or | 1 |
91 | benefit=1.07 | 1 |
92 | bioavailabilty | 4 |
93 | blueshifts | 1 |
94 | bmi-p | 1 |
95 | bvba | 2 |
96 | ca-mssa | 10 |
97 | cal/pd | 2 |
98 | cals | 3 |
99 | camber | 10 |
100 | centile | 215 |
101 | centiles | 30 |
102 | cfu/carcass | 9 |
103 | cfu/serving | 1 |
104 | coefficent | 4 |
105 | cost-effectiveness.we | 1 |
106 | cost/child | 1 |
107 | cost/responder | 1 |
108 | cost/treated | 1 |
109 | dimethylethanamine | 1 |
110 | dimethylthiazol-2-yl | 1 |
111 | dinitrotoluene | 3 |
112 | down-pack | 5 |
113 | dystrophica | 2 |
114 | eckenrode | 1 |
115 | elipscity | 1 |
116 | fold-changes | 3 |
117 | gvr | 4 |
118 | hazard=0.52 | 1 |
119 | hazard=2.61 | 1 |
120 | hazard=2.72 | 1 |
121 | hfb2 | 3 |
122 | humidities | 23 |
123 | humidity | 1,342 |
124 | humidity-transorally | 1 |
125 | hydroxy-1 | 1 |
126 | hydroxyhexanoate | 1 |
127 | hypaque | 2 |
128 | hypopnoe | 1 |
129 | inflammatory-analgesic | 1 |
130 | m=28.0 | 1 |
131 | map/ne | 2 |
132 | mcfb | 6 |
133 | mean=32.7±3.7 | 1 |
134 | memory-i | 1 |
135 | mentaux | 1 |
136 | methyl-1,2,3,4-tetrahydroisoquinoline | 1 |
137 | mr-spectroscopy | 2 |
138 | nlmixed | 5 |
139 | normogram | 3 |
140 | odds=3.5 | 1 |
141 | ohe1/4-ohe1 | 1 |
142 | percentile | 1,875 |
143 | percentiles | 394 |
144 | picturata | 5 |
145 | pm400 | 1 |
146 | pmca50 | 3 |
147 | pre-lagb | 1 |
148 | pre-rygbp | 1 |
149 | qmc | 1 |
150 | ranges | 1,890 |
151 | rank.=6.8 | 1 |
152 | rank=3.93 | 1 |
153 | rank=9.953 | 1 |
154 | rate=0.6 | 1 |
155 | rate=1.2 | 2 |
156 | rate=1.56-1.99 | 1 |
157 | response=0.0036 | 1 |
158 | risk:1.67 | 1 |
159 | risk=0.05 | 1 |
160 | risk=0.11 | 1 |
161 | risk=0.36 | 2 |
162 | risk=0.38 | 1 |
163 | risk=0.39 | 1 |
164 | risk=0.46 | 1 |
165 | risk=0.51 | 1 |
166 | risk=0.52 | 1 |
167 | risk=0.54 | 1 |
168 | risk=0.59 | 1 |
169 | risk=0.60 | 1 |
170 | risk=0.61 | 1 |
171 | risk=0.62 | 1 |
172 | risk=0.70 | 1 |
173 | risk=0.72 | 2 |
174 | risk=0.73 | 1 |
175 | risk=0.75 | 2 |
176 | risk=0.76 | 1 |
177 | risk=0.84 | 1 |
178 | risk=0.85 | 1 |
179 | risk=0.86 | 3 |
180 | risk=0.91 | 1 |
181 | risk=0.96 | 1 |
182 | risk=0.98 | 1 |
183 | risk=1.06 | 1 |
184 | risk=1.063 | 1 |
185 | risk=1.1 | 2 |
186 | risk=1.13 | 2 |
187 | risk=1.14 | 1 |
188 | risk=1.17 | 2 |
189 | risk=1.2 | 1 |
190 | risk=1.20 | 3 |
191 | risk=1.21 | 1 |
192 | risk=1.27 | 1 |
193 | risk=1.33 | 1 |
194 | risk=1.36 | 1 |
195 | risk=1.7 | 3 |
196 | risk=1.78 | 1 |
197 | risk=1.79 | 1 |
198 | risk=2.22 | 1 |
199 | risk=2.57 | 1 |
200 | risk=3.04 | 1 |
201 | risk=3.51 | 1 |
202 | risk=3.83 | 1 |
203 | risk=4.4 | 1 |
204 | risk=4.47 | 1 |
205 | risk=4.7 | 1 |
206 | risk=8.8 | 1 |
207 | risks=0.79 | 1 |
208 | rr=-0.169-0.0499*hdl-c | 1 |
209 | rr=-0.367+0.077*hdl-c | 1 |
210 | rr=1.07-0.185*hdl-c | 1 |
211 | s-fimh1-25 | 1 |
212 | score≥5=17 | 1 |
213 | seriality | 1 |
214 | serotec | 1 |
215 | small-worldness | 5 |
216 | spc30 | 1 |
217 | superreviewer | 1 |
218 | terms.however | 1 |
219 | tert-butyl-phenylaminooxalyl | 1 |
220 | tetrahydro-4h-carbazol-4-one | 1 |
221 | vs.10th | 2 |
222 | weibul | 1 |
223 | ytss | 2 |
224 | z-score | 595 |
225 | z-score=-0.63 | 1 |
226 | z-score=0.6 | 1 |
227 | z-scores | 345 |
228 | z-score≤-1.5 | 1 |
229 | ~30kg/m | 1 |
230 | ~42.5°c | 1 |
231 | °cd | 4 |
232 | µv/y | 1 |
233 | μv/y | 1 |
234 | ∼0.7°c | 1 |
235 | ∼1◦c | 1 |
236 | ∼39.0°c | 1 |
237 | ≈34°c | 1 |
238 | ≈39°c | 1 |
239 | ≤-2.0 | 1 |
240 | ≤-2.5 | 12 |
241 | ≤-2.8 | 1 |
242 | ≤-3.0 | 1 |
243 | ≤24kg/m | 1 |
244 | ≤3.2 | 8 |
245 | ≤43.0 | 1 |
246 | ≥0.50 | 2 |
247 | ≥15/h | 2 |
248 | ≥25kg/m | 1 |
249 | ≥37·5°c | 2 |
250 | ≥38·0°c | 1 |
251 | ≥40.0 | 1 |
252 | ≥500copies/ml | 1 |
253 | ≥5µg/dl | 1 |
1 | 40.0+ | 1 |
2 | 100°f+ | 1 |
3 | 58- | 2 |
4 | ≥40.0 | 1 |
5 | 25.2±1.0 | 1 |
6 | 58.6±1.0 | 1 |
7 | ≤-2.0 | 1 |
8 | ≤-3.0 | 1 |
9 | ≤43.0 | 1 |
10 | 24.4+/-4.0 | 1 |
11 | m=28.0 | 1 |
12 | 35.0/100,000 | 1 |
13 | pm400 | 1 |
14 | risk=1.20 | 3 |
15 | spc30 | 1 |
16 | ≥0.50 | 2 |
17 | pmca50 | 3 |
18 | risk=0.60 | 1 |
19 | =14.48±1.60 | 1 |
20 | risk=0.70 | 1 |
21 | 3.680 | 2 |
22 | hydroxy-1 | 1 |
23 | 33.9+/-1.1 | 1 |
24 | risk=1.1 | 2 |
25 | 0.88-log1.01 | 1 |
26 | risk=0.11 | 1 |
27 | 24.1±11 | 1 |
28 | 36·11 | 1 |
29 | risk=1.21 | 1 |
30 | risk=0.51 | 1 |
31 | risk=3.51 | 1 |
32 | risk=0.61 | 1 |
33 | hazard=2.61 | 1 |
34 | risk=0.91 | 1 |
35 | ohe1/4-ohe1 | 1 |
36 | rate=1.2 | 2 |
37 | risk=1.2 | 1 |
38 | 24.0±2.2 | 1 |
39 | 31.8±2.2 | 1 |
40 | ≤3.2 | 8 |
41 | 58.7+/-16.2 | 1 |
42 | risk=2.22 | 1 |
43 | 1.26-2.42 | 1 |
44 | hazard=0.52 | 1 |
45 | risk=0.52 | 1 |
46 | risk=0.62 | 1 |
47 | risk=0.72 | 2 |
48 | hazard=2.72 | 1 |
49 | .78-.92 | 1 |
50 | 72.29+/-6.92 | 1 |
51 | hfb2 | 3 |
52 | 29+/-4.3 | 1 |
53 | 31.6+/-5.3 | 1 |
54 | risk=1.13 | 2 |
55 | risk=1.33 | 1 |
56 | rank=9.953 | 1 |
57 | z-score=-0.63 | 1 |
58 | risk=1.063 | 1 |
59 | risk=0.73 | 1 |
60 | risk=3.83 | 1 |
61 | rank=3.93 | 1 |
62 | 61.0±13.4 | 1 |
63 | risk=4.4 | 1 |
64 | 19.3-26.4 | 1 |
65 | 28.0+/-7.4 | 1 |
66 | risk=3.04 | 1 |
67 | risk=1.14 | 1 |
68 | risk=0.54 | 1 |
69 | risk=0.84 | 1 |
70 | 26·4 | 1 |
71 | -2.6+/-0.5 | 1 |
72 | -2.7+/-0.5 | 1 |
73 | 36.5±20.5 | 1 |
74 | z-score≤-1.5 | 1 |
75 | ≤-2.5 | 12 |
76 | odds=3.5 | 1 |
77 | 28±3.5 | 1 |
78 | risk=0.05 | 1 |
79 | s-fimh1-25 | 1 |
80 | 19.8-25 | 1 |
81 | -86+/-75 | 1 |
82 | risk=0.75 | 2 |
83 | risk=0.85 | 1 |
84 | 29±5 | 1 |
85 | z-score=0.6 | 1 |
86 | rate=0.6 | 1 |
87 | risk=1.06 | 1 |
88 | risk=0.36 | 2 |
89 | risk=1.36 | 1 |
90 | response=0.0036 | 1 |
91 | risk=0.46 | 1 |
92 | risk=0.76 | 1 |
93 | risk=0.86 | 3 |
94 | 6686 | 2 |
95 | risk=0.96 | 1 |
96 | 48.2±10.7 | 1 |
97 | risk=1.7 | 3 |
98 | 25.96+/-3.7 | 1 |
99 | 21.7±3.7 | 1 |
100 | mean=32.7±3.7 | 1 |
101 | risk=4.7 | 1 |
102 | 36.9±5.7 | 1 |
103 | =29.7 | 1 |
104 | 1.52+/-0.07 | 1 |
105 | benefit=1.07 | 1 |
106 | risk=1.17 | 2 |
107 | +0.017 | 1 |
108 | score≥5=17 | 1 |
109 | risk=1.27 | 1 |
110 | risk=4.47 | 1 |
111 | risk=2.57 | 1 |
112 | risk:1.67 | 1 |
113 | =0.877 | 2 |
114 | ≤-2.8 | 1 |
115 | rank.=6.8 | 1 |
116 | risk=8.8 | 1 |
117 | risk=0.38 | 1 |
118 | risk=1.78 | 1 |
119 | risk=0.98 | 1 |
120 | 33.8±3.9 | 1 |
121 | 47.8+/-4.9 | 1 |
122 | 19.0-24.9 | 2 |
123 | 1.79+/-0.39 | 2 |
124 | risk=0.39 | 1 |
125 | risk=0.59 | 1 |
126 | 61/59 | 2 |
127 | risks=0.79 | 1 |
128 | risk=1.79 | 1 |
129 | rate=1.56-1.99 | 1 |
130 | 5000-14,999 | 1 |
131 | 20,000-24,999 | 1 |
132 | 15,000-19,999 | 1 |
133 | 25,000-29,999 | 1 |
134 | area-under-the-hba | 2 |
135 | bvba | 2 |
136 | dystrophica | 2 |
137 | ca-mssa | 10 |
138 | picturata | 5 |
139 | acquisita | 12 |
140 | mcfb | 6 |
141 | pre-lagb | 1 |
142 | rr=1.07-0.185*hdl-c | 1 |
143 | rr=-0.367+0.077*hdl-c | 1 |
144 | rr=-0.169-0.0499*hdl-c | 1 |
145 | serotec | 1 |
146 | inflammatory-analgesic | 1 |
147 | qmc | 1 |
148 | ∼1◦c | 1 |
149 | ∼39.0°c | 1 |
150 | 1200-1400°c | 1 |
151 | +10°c | 2 |
152 | ≥38·0°c | 1 |
153 | 14±3.1°c | 1 |
154 | ≈34°c | 1 |
155 | ~42.5°c | 1 |
156 | ≥37·5°c | 2 |
157 | 47-96°c | 1 |
158 | ∼0.7°c | 1 |
159 | 62·8°c | 1 |
160 | ≈39°c | 1 |
161 | °cd | 4 |
162 | cost/treated | 1 |
163 | nlmixed | 5 |
164 | cost/child | 1 |
165 | cal/pd | 2 |
166 | eckenrode | 1 |
167 | centile | 215 |
168 | percentile | 1,875 |
169 | map/ne | 2 |
170 | dinitrotoluene | 3 |
171 | methyl-1,2,3,4-tetrahydroisoquinoline | 1 |
172 | dimethylethanamine | 1 |
173 | tetrahydro-4h-carbazol-4-one | 1 |
174 | hypopnoe | 1 |
175 | z-score | 595 |
176 | hydroxyhexanoate | 1 |
177 | hypaque | 2 |
178 | 'evaporative | 1 |
179 | cost-effectiveness.we | 1 |
180 | 210g | 1 |
181 | 489-1696g | 1 |
182 | cfu/serving | 1 |
183 | 36.5/h | 1 |
184 | ≥15/h | 2 |
185 | vs.10th | 2 |
186 | 85-97th | 1 |
187 | memory-i | 1 |
188 | down-pack | 5 |
189 | arabesk | 1 |
190 | 41ng/l | 1 |
191 | 2.0+/-0.39mg/dl | 1 |
192 | ≥5µg/dl | 1 |
193 | 1.490ng/ml | 1 |
194 | ≥500copies/ml | 1 |
195 | weibul | 1 |
196 | dimethylthiazol-2-yl | 1 |
197 | tert-butyl-phenylaminooxalyl | 1 |
198 | -methyl-2-oxobutyl | 1 |
199 | 14,400/μl | 1 |
200 | 32.2±1.0kg/m | 1 |
201 | ~30kg/m | 1 |
202 | 26±1kg/m | 1 |
203 | 22±2kg/m | 1 |
204 | 23.0-27.4kg/m | 1 |
205 | ≤24kg/m | 1 |
206 | ≥25kg/m | 1 |
207 | 33±5kg/m | 1 |
208 | 24.9±0.6kg/m | 1 |
209 | 22.3±1.6kg/m | 1 |
210 | 22.1±1.7kg/m | 1 |
211 | 18.5-22.9kg/m | 1 |
212 | normogram | 3 |
213 | 169±12cm | 1 |
214 | 5.1mm | 2 |
215 | 3/min | 2 |
216 | bmi-p | 1 |
217 | pre-rygbp | 1 |
218 | camber | 10 |
219 | cost/responder | 1 |
220 | terms.however | 1 |
221 | superreviewer | 1 |
222 | benefit-or | 1 |
223 | gvr | 4 |
224 | 34.2yr | 1 |
225 | fold-changes | 3 |
226 | ranges | 1,890 |
227 | humidities | 23 |
228 | centiles | 30 |
229 | percentiles | 394 |
230 | z-scores | 345 |
231 | 35months | 1 |
232 | cals | 3 |
233 | 31.0±3.2years | 1 |
234 | 64±12years | 1 |
235 | 68±12years | 1 |
236 | 6-86years | 1 |
237 | cfu/carcass | 9 |
238 | small-worldness | 5 |
239 | ytss | 2 |
240 | blueshifts | 1 |
241 | coefficent | 4 |
242 | mentaux | 1 |
243 | µv/y | 1 |
244 | μv/y | 1 |
245 | 40y | 1 |
246 | 11y | 7 |
247 | humidity-transorally | 1 |
248 | mr-spectroscopy | 2 |
249 | anniversary | 47 |
250 | elipscity | 1 |
251 | humidity | 1,342 |
252 | seriality | 1 |
253 | bioavailabilty | 4 |